Blood Thinners May Face Increased Bleeding Risks During Respiratory Tract Infections: Study
A new study links respiratory tract infections to an increased risk of bleeding events in patients taking commonly used blood thinners.
Tag Archives: Pradaxa
-
-
Eliquis More Effective At Preventing Recurring Blood Clots, Embolism, Than Xarelto: Study
Users of the blood thinner Xarelto had higher risks of recurrent venous thromboembolism and higher risks of bleeding events than those taking Eliquis, according to the findings of a new…
-
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
CDC researchers report that blood thinners and insulin account for the largest number of emergency room visits due to adverse drug reactions.
-
Fatal Bleeding Still Occurring With New Blood Thinners Despite Antidotes: Study
A new study reveals that death rates from bleeding events linked to new blood thinners like Pradaxa and Xarelto are still high, despite the introduction of reversal agents meant to…
-
Many Prescribed Aspirin With Blood Thinners, Despite Bleeding Risk And No Clear Benefits: Study
A new study indicates there are few, if any, benefits to taking aspirin with blood thinners like Xarelto and Eliquis, while the combo increases patient bleeding risks.
-
Biaxin Linked To Increased Risk Of Bleeding Compared to Zithromax: Study
A new study links the antibiotic Biaxin and similar antibiotics to an increased risk of major bleeding events.
-
Aspirin Just As Good As Other Blood Thinners At Preventing Clots Following Hip, Knee Joint Surgery
A new study finds that aspirin is just as safe and effective as more powerful blood thinners at preventing life-threatening blood clots following surgery, but is far more cost effective.
-
Aspirin With Blood Thinners Like Xarelto, Eliquis, Led To Increased Bleeding Risks, Few Benefits: Study
A new study warns that combining aspirin with blood thinners like Pradaxa, Xarelto and Eliquis provides few benefits and may increase bleeding risks,
-
Jury Awards $540K in Pradaxa Trial Against Boehringer Ingelheim
A Connecticut jury has ordered the makers of Pradaxa to pay more than half a million dollars to a New York man who suffered a life-threatening gastrointestinal bleeding event.
-
Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks
Boehringer-Ingelheim has been ordered to pay $1.25 million to the family of a woman who died of Pradaxa gastrointestinal bleeding side effects.
